Advancements in Blood Platelet Production Using Fat-Derived Stem Cells

Importance of Blood Platelets

Blood platelets play a crucial role in wound healing. Upon injury, platelets aggregate to form clots that effectively halt bleeding. Numerous patients require platelet transfusions when their platelet count diminishes due to chemotherapy, cancer, infections, or other conditions. However, these transfusions face challenges, as donor platelets have a limited shelf life and pose a high risk of infection or rejection.

The Need for Alternative Solutions

Given the difficulties associated with platelet transfusions, there is a pressing need for innovative methods to produce platelets independently of donors.

New Research Findings

In a recent publication in the Blood journal, Tozawa and colleagues present a groundbreaking technique for producing blood platelets in vitro, eliminating the need for donor sources. The researchers sourced stem cells from adipose tissue, or fat, to create new stem cell cultures.

Successful Cultivation of Platelets

By utilizing adipose-derived cell lines obtained from a small volume of fat, the researchers successfully developed stable stem cell lines capable of generating blood platelets without the introduction of any genes. Notably, these cell lines demonstrated no mutations that could compromise their platelet-producing abilities.

The team cultivated platelets from these stem cells that resembled those derived from donor blood. While these platelets did not aggregate without external stimulation, they also exhibited different responses to various stimuli compared to donor-derived platelets. It is important to note that not all stem cell lines were able to produce platelets.

Implications for Patient Care

The findings from Tozawa and colleagues hold significant potential for establishing new methodologies for in vitro blood platelet production, thereby reducing reliance on donor blood. This advancement could greatly enhance the availability of platelet transfusions for patients in need, ultimately improving patient care. However, further research is required to develop a consistently producing stem cell line.

Reference

Tozawa et al. 2019. Unique megakaryocytes and platelets from novel human adipose-derived mesenchymal stem cell lines. Blood Journal.